Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))

Greenberg, R. N., Hurley, M. Y., Dinh, D. V., Mraz, S., Vera, J. G., Von Bredow, D., … Chaplin, P. (2015, November 10). Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802)). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0142802